Tom Sellig, Adare Pharma Solutions CEO

CD­MO Adare Phar­ma So­lu­tions di­vests its post­bi­ot­ic di­vi­sion

Adare Phar­ma So­lu­tions di­vest­ed a busi­ness that man­u­fac­tures post­bi­ot­ic prod­ucts to dsm-fir­menich, a Dutch man­u­fac­tur­er that sells a range of prod­ucts, in­clud­ing nu­traceu­ti­cals and vi­t­a­mins …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.